Has Nancy Davis received payments from drug or device companies?

Yes. Drug and device makers reported $14,512 in general payments to Nancy Davis across 13 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nancy Davis did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nancy Davis come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nancy Davis

Internal Medicine · Nashville, TNNPI 1932153244

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $14,138 of the $14,512 with a category attached, or 97.4%. Janssen Research & Development, LLC accounts for 97.4% of it on its own, with 5 other manufacturers making up the rest. 2023 is the largest year on record at $10,540, more than ten times the $676 reported in 2021. Among internal medicine clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,512in general payments, 2019–2025

Across 13 payments — averaging $1116.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Janssen Research & Development, LLC$14K
E.r. Squibb & Sons, L.L.C.$161
Exelixis Inc.$107
Sumitomo Pharma America, Inc.$75
Acrotech Biopharma Inc.$26
Merck$5

$970,840in research payments, 2019–2025

Across 329 payments — averaging $2950.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

E.r. Squibb & Sons, L.L.C.$302K
Merck$200K
Incyte Corporation$165K
AstraZeneca$124K
Gilead$112K
Mirati Therapeutics, Inc.$23K
plus $44K from 5 others

What the payments were for

Consulting fees$14,13897%
Food & beverage$3492%
Education$260%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Janssen Research & Development, LLC	6	$14,138
E.r. Squibb & Sons, L.L.C.	2	$161
Exelixis Inc.	1	$107
Sumitomo Pharma America, Inc.	1	$75
Acrotech Biopharma Inc.	2	$26
Merck	1	$5

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OPDIVO$115
Cabometyx$107

How this compares

$14,512 in reported general payments places this provider in the 95th percentile of 2,216 internal medicine providers in Tennessee.

See all internal medicine providers in Tennessee →

Other internal medicine in Nashville

John AndersonNashville$1.5M
Temidayo AbeNashville$113K
Wayne RileyNashville$86K
Leah CordovezNashville$64K
Asad Al AboudNashville$44K
Mark KouryNashville$41K
David HeusinkveldNashville$24K
Charlotte LohreyNashville$19K
Malek Al-OmaryNashville$18K
James GekasNashville$17K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →